Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

  • STATUS
    Not Recruiting
  • participants needed
    2000
  • sponsor
    Genfit
Updated on 26 January 2021
Investigator
GENFIT
Primary Contact
Dim Clinica Privada (3.1 mi away) Contact
+322 other location

Summary

The primary objectives of this study are to evaluate the effect of Elafibranor treatment compared to placebo on 1) histological improvement and 2) all-cause mortality and liver-related outcomes in patients with nonalcoholic steatohepatitis (NASH) and fibrosis.

Details
Condition Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Treatment Placebo, Elafibranor
Clinical Study IdentifierNCT02704403
SponsorGenfit
Last Modified on26 January 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note